WORXE Worlds Online Inc

Chews Love: MariMed Launches Cannabis-Infused Betty’s Eddies™ “Smashin’ Passion” Aphrodisiac Chews

Chews Love: MariMed Launches Cannabis-Infused Betty’s Eddies™ “Smashin’ Passion” Aphrodisiac Chews

  • New passionfruit-flavored cannabis edibles made with four all-natural aphrodisiac ingredients
  • Available for Valentine’s Day in MA, NV, and RI; widely available in other markets by March 2021
  • Marks 10th flavor and formulation for award-winning Betty’s Eddies brand

NORWOOD, Mass., Jan. 28, 2021 (GLOBE NEWSWIRE) -- Move over, flowers and chocolate. Leading multi-state cannabis operator MariMed Inc. (MRMD:OTCQX) (the “Company” or “MariMed”) is heating up the cannabis edibles market in time for Valentine’s Day with the release of its Betty’s Eddies™ Smashin’ Passion chews. Scientifically formulated to stimulate mind and body, Smashin’ Passion chews will be available starting in February at the Company’s spacious Panacea Wellness dispensary in Middleboro, MA, and later at select dispensaries in Massachusetts, Nevada, Rhode Island, and Puerto Rico.

The tenth addition to the award-winning Betty’s Eddies line of all-natural fruit chews, Smashin’ Passion chews are made with pure freeze-dried passionfruit and a proprietary blend of four all-natural aphrodisiacs: damiana, horny goat weed, maca root, and muira puama.

“We are incredibly excited to spice up dispensary shelves – and nightstand drawers – with Betty’s tenth flavor and formulation,” explained Ryan Crandall, Chief Product Officer and SVP of Sales at MariMed. “Smashin’ Passion truly is a labor of love for the thousands of patients and consumers who’ve made Betty’s Eddies one of the top-selling edibles in the US.”

Betty's Eddies was named 2020 Edible of the Year by the Explore Maryland Cannabis Awards and is the 2019 LeafLink Winner for Best Selling Medical Product. Sought after for their tempting flavors, mouth-watering texture, and reliable effects, all Betty’s Eddies fruit chews are gluten-free, vegan, and made with organically grown fruits and vegetables. For information, sales, and availability of Smashin’ Passion and all other flavors, please visit Betty’s Eddies at .

About MariMed

MariMed Inc., a multi-state cannabis operator, is dedicated to improving the health and wellness of people through the use of cannabinoids and cannabis products. The Company develops, owns, and manages seed to sale state-licensed cannabis facilities, which are models of excellence in horticultural principles, cannabis cultivation, cannabis-infused products, and dispensary operations. MariMed has an experienced management team that has produced consistent growth and success for the Company and its managed business units.

The Company is at the forefront of science and innovation through research developed by its lab technicians and medical advisors resulting in industry-leading products and brands, including Betty's Eddies™, Nature’s Heritage™, Bourne Baking Co., and Kalm Fusion™. These precision-dosed products are focused on specific symptoms and conditions and are licensed and distributed across the country. For additional information, visit .

Important Caution Regarding Forward-Looking Statements:

This release contains certain forward-looking statements and information relating to MariMed Inc. that is based on the beliefs of MariMed Inc.'s management, as well as assumptions made by and information currently available to the Company. Such statements reflect the current views of the Company with respect to future events, including estimates and projections about its business based on certain assumptions of its management, including those described in this Release. These statements are not guarantees of future performance and involve risk and uncertainties that are difficult to predict, including, among other factors, changes in demand for the Company's services and products, changes in the law and its enforcement and changes in the economic environment. Additional risk factors are included in the Company's public filings with the SEC. Should one or more of these underlying assumptions prove incorrect, actual results may vary materially from those described herein as "hoped," "anticipated," "believed," "planned, "estimated," "preparing," "potential," "expected," "looks" or words of a similar nature. The Company does not intend to update these forward-looking statements. None of the content of any of the websites referred to herein (even if a link is provided for your convenience) is incorporated into this release and the Company assumes no responsibility for any of such content.

All trademarks and service marks are the property of their respective owners.

Company Contact

Jon Levine, CFO

MariMed Inc.

Tel (781) 559-8713

Media Contact

Beth Waterfall

MariMed Inc.



T: 781-619-8539

Investors

KCSA Strategic Communications

Scott Eckstein / Elizabeth Barker



EN
28/01/2021

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Worlds Online Inc

 PRESS RELEASE

MariMed’s InHouse Brand Again Supports Veterans Facing Housing Challen...

MariMed’s InHouse Brand Again Supports Veterans Facing Housing Challenges With Second Annual Help on the Homefront Campaign Local Veterans in Maryland, Massachusetts, Delaware, and Illinois Can Enter to Win $5,000 to Help Offset the Cost of Housing or Home Improvements through November 30 NORWOOD, Mass., Oct. 01, 2025 (GLOBE NEWSWIRE) -- InHouse™ announced today the launch of its second annual campaign, a philanthropic effort that provides veterans the chance to win funds to help offset their cost of housing or home improvements. Help on the Homefront debuted in 2024 to raise awareness...

 PRESS RELEASE

MariMed Announces Third Quarter 2025 Earnings Date

MariMed Announces Third Quarter 2025 Earnings Date NORWOOD, Mass., Sept. 29, 2025 (GLOBE NEWSWIRE) -- . (“MariMed” or the “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading cannabis consumer packaged goods company and retailer, announced today it will report its third quarter 2025 financial results on November 5, 2025 after the markets close. Management will host a conference call on November 6, 2025 at 8:00 a.m. EDT to discuss financial results. A webcast will be available and can be accessed via MariMed’s Investor Relations website at . A playback of the call will also be made available o...

 PRESS RELEASE

MariMed’s Betty’s Eddies Spreads Importance of Cancer Screening Educat...

MariMed’s Betty’s Eddies Spreads Importance of Cancer Screening Education and Awareness through Partnership with Keep A Breast Foundation Third Annual Collaboration Coincides with Breast Cancer Awareness Month NORWOOD, Mass., Sept. 23, 2025 (GLOBE NEWSWIRE) -- announced its third annual collaboration with the Keep A Breast Foundation (“KAB”), furthering its commitment to breast cancer awareness, early screening education, and community support. After years of hearing from patients and consumers who have used Betty’s Eddies to help cope with treatment-related ailments, the brand is cont...

 PRESS RELEASE

MariMed Reports Second Quarter 2025 Earnings

MariMed Reports Second Quarter 2025 Earnings NORWOOD, Mass., Aug. 06, 2025 (GLOBE NEWSWIRE) -- (“MariMed” or the “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, today announced its financial results for the second quarter ended June 30, 2025. Management Commentary “We delivered growth and expanded operations across our business during the second quarter, continuing our progress of building a leading cannabis consumer packaged goods company,” said Jon Levine, MariMed Chief Executive Officer. “Our ‘Expand the Brand’ ...

 PRESS RELEASE

MariMed’s Products to Enter Pennsylvania Market Through a Management S...

MariMed’s Products to Enter Pennsylvania Market Through a Management Services and Licensing Agreement with TILT Holdings NORWOOD, Mass., July 31, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed,” “the Company”) (CSE: MRMD) (OTCQX: MRMD), a leading cannabis consumer packaged goods company and retailer, today announced a strategic agreement with TILT Holdings (“TILT”) (CBOE: TILT) (OTCPK: TLLTF) that will expand the distribution of the Company’s award-winning portfolio of medical marijuana products to Pennsylvania. On July 30, 2025, Standard Farms, LLC (“Standard Farms”), a wholly owned su...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch